Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis | |
Wang Q.; Yan Y.; Zhang J.; Guo P.; Xing Y.; Wang Y.; Qin F.; Zeng Q. | |
刊名 | Biomedicine and Pharmacotherapy
![]() |
2018 | |
卷号 | 104页码:28-35 |
关键词 | Apoptosis ccRCC Glycolysis HK2 PG |
DOI | 10.1016/j.biopha.2018.05.013 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4582561 |
专题 | 山东大学 |
作者单位 | 1.Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong, China 2.Shandong Provincial Hospital affiliated to |
推荐引用方式 GB/T 7714 | Wang Q.,Yan Y.,Zhang J.,et al. Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis[J]. Biomedicine and Pharmacotherapy,2018,104:28-35. |
APA | Wang Q..,Yan Y..,Zhang J..,Guo P..,Xing Y..,...&Zeng Q..(2018).Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis.Biomedicine and Pharmacotherapy,104,28-35. |
MLA | Wang Q.,et al."Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis".Biomedicine and Pharmacotherapy 104(2018):28-35. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论